5 Best Healthcare Stocks to Buy According to Billionaire Larry Robbins

3. Baxter International Inc. (NYSE:BAX)

Glenview Capital Management’s Stake Value: $139,573,000

Percentage of Lee Munder Capital Group’s 13F Portfolio: 3.49%

Number of Hedge Fund Holders: 37

Founded in 1931, Baxter International Inc. (NYSE:BAX) is one of the world’s oldest and largest healthcare product providers, with an array of products across different medical categories. Since the start of 2022, Baxter International Inc.’s (NYSE:BAX) stock has lost more than one-third of its value amid a slew of bad news surrounding the company, including product recalls, disappointing quarterly numbers and guidance, and supply-chain disruptions.

Late last month Baxter International Inc. (NYSE:BAX) announced that the United States Food and Drug Administration (FDA) had granted 501k clearance for its Novum IQ syringe infusion pump (SYR) with Dose IQ Safety Software. On September 13, Bloomberg reported that Baxter International Inc. (NYSE:BAX) is considering the sale of its two renal care business units. The combined value of these two units is estimated to be under $1 billion, and private equity firms could show interest in acquiring them.